Article | March 26, 2013

MHRA's Summary Of PV Systems (SPS) Document

Source: Sentrx

By Bart Cobert

As everyone who deals with the EU and the UK in drug safety knows, the EMA issued a new set of Good PV Guidelines to replace (largely) Volume 9A. These are more than “guidelines” in the US sense where guidelines represent FDAs current thoughts on the matters addressed but are not binding.  In the EU, these guidelines are binding.

For the past several years the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has been using a document called the Summary of Pharmacovigilance Systems (SPS or SPVS).

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: